Hc Advisors, LLC Eli Lilly & CO Transaction History

Hc Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $43,470 - $59,929	-100 Reduced 2.17%	4,504 $2.42 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $38,230 - $51,118	-109 Reduced 2.31%	4,604 $2.16 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $33,858 - $39,765	109 Added 2.37%	4,713 $1.62 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $32,155 - $37,467	100 Added 2.22%	4,604 $1.68 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $101,178 - $118,799	-363 Reduced 7.46%	4,504 $1.46 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $899 - $1,116	4 Added 0.08%	4,867 $1.34 Million
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $353,452 - $434,972	1,595 Added 48.81%	4,863 $1.12 Million
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $590,037 - $763,208	3,268 New	3,268 $750,000
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $1.37 Million - $1.59 Million	-9,403 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $1.28 Million - $1.54 Million	9,403 New	9,403 $1.54 Million
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $1.15 Million - $1.42 Million	-9,638 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $1.03 Million - $1.28 Million	9,638 New	9,638 $1.27 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.